Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 799 results for "continuous renal replacement therapy"

Continuous Renal Replacement Therapy (CRRT) Market: Challenges...

Transparency Market Research Report Added "Continuous Renal Replacement Therapy Market" to its database. This press release was orginally distributed by SBWire Albany, NY -- ( SBWIRE ) -- 04/14/2016 -- Global CRRT Market: Overview Acute ... Digital Journal, 2 weeks ago
Renal Replacement Therapy Equipment and Consumables NHS SupplyChain, 3 weeks ago
[x]  

Potential Survival Benefit of Polymyxin B Hemoperfusion in Septic Shock Patients on Continuous Renal Replacement Therapy: A Propensity-Matched Analysis

Background/Aims: We assessed the survival benefit of polymyxin B hemoperfusion (PMX) in septic shock patients starting continuous renal replacement therapy (CRRT), who are known to have an increased rate of mortality. Methods: Adult patients in the ...
 Blood Purification2 months ago

Bluegrass Vascular Technologies Announces First Clinical Use Of Catheter System

The Surfacer System enables end-stage renal disease patient with obstructed central veins to continue hemodialysis therapy San Antonio, TX /PRNewswire/ - Bluegrass Vascular Technologies, Inc. (BVT), a private medical technology company focused on ...
 Bioresearch Online1 month ago First Use of Bluegrass Surfacer Inside-Out Access Catheter System Performed in Europe  Endovascular Today1 month ago Bluegrass Vascular Technologies, Inc. Announces First Clinical Use Of The Surfacer Inside-Out Access Catheter System In Europe  BioSpace1 month ago
[x]  

Neutrophil gelatinase-associated lipocalin elimination by renal replacement therapy: minding the membrane!

Letter Open Access Critical Care 2016 20 :87 DOI: 10.1186/s13054-016-1258-9 Honore and spapen.2016 Published: 5April2016 The Letter to this article has been published in Critical Care 2016 20 :20 This comment refers to ...
 Critical Care3 weeks ago

Patient Dosing Initiated for OMS721 Phase 2 Program in Renal Diseases

SEATTLE--( BUSINESS WIRE )--Omeros Corporation(NASDAQ: OMER) today announced initiation of patient dosing in its OMS721 Phase 2 program in corticosteroid-dependent renal diseases. The Phase 2 clinical trial of OMS721, the company's lead ...
 Business Wire1 week ago Omeros Corporation Release: Patient Dosing Initiated For OMS721 Phase 2 Program In Renal Diseases  BioSpace1 week ago OMEROS : Patient Dosing Initiated for OMS721 Phase 2 Program in Renal Diseases  4 Traders1 week ago Omeros Corporation Initiates its Phase 3 Program for OMS721 in aHUS Following Meeting with FDA  Business Wire1 month ago
[x]  

Patients with Fabry Disease after Enzyme Replacement Therapy Dose Reduction and Switch-2-Year Follow-Up

* , Sima Canaan-Kühl † , Johannes Krämer ‡ § , Thomas Duning ‖ , Stefanie Reiermann * , Claudia Sommer § ¶ , Jörg Stypmann ** , Daniela Blaschke †† , Nurcan Üçeyler § ¶ , Hans-Werner Hense ‡‡ , Stefan-Martin Brand ...
 Journal American Society of Nephrology2 months ago

Aytu BioScience Acquires U.S. Commercial Rights To Natesto

Aytu BioScience Enters $2 Billion Testosterone Replacement Market With Acquisition Of U.S. Commercial Rights To Natesto ENGLEWOOD, Colo. , April 25, 2016 /PRNewswire/ —Aytu BioScience, Inc. (OTCQX: AYTU), a specialty pharmaceutical company ...
 Pharma Live4 days ago Aytu BioScience, Inc. (AYTU: OTCQX U.S. Premier) | Aytu BioScience Enters $2 Billion Testosterone Replacement Market with Acquisition of U.S. Commercial Rights to Natesto®  OTC Markets5 days ago Aytu BioScience Enters $2 Billion Testosterone Replacement Market with Acquisition of U.S. Commercial Rights to Natesto®  Bloomberg5 days ago Aytu BioScience Enters 2 Billion Testosterone Replacement Market with Acquisition of US Commercial Rights to Natesto  Pharma Focus Asia4 days ago
[x]  

Bristol-Myers Squibb's Opdivo® (nivolumab) Receives Breakthrough Therapy Designation from U.S. Food and Drug Administration for Previously Treated Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck

PRINCETON, N.J.--(Business Wire)-- Bristol-Myers Squibb Company (NYSE: BMY) announced today that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation to Opdivo for the potential indication of recurrent or ...
 Digital Journal5 days ago Bristol-Myers Squibb's Opdivo(R) (nivolumab) Receives Breakthrough Therapy Designation from U.S. Food and Drug Administration for Previously Treated Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck  TradingCharts.com4 days ago Merck Receives Breakthrough Therapy Designation from U.S. Food and Drug Administration for KEYTRUDA® (pembrolizumab) in Classical Hodgkin Lymphoma (cHL)  Yahoo! Singapore1 week ago MERCK : Receives Breakthrough Therapy Designation from U.S. Food and Drug Administration for KEYTRUDA® (pembrolizumab) in Classical Hodgkin Lymphoma (cHL)  4 Traders1 week ago
[x]  

Bio Products Laboratory, Ltd Announces FDA Submission of Biologics License Supplement for Gammaplex 10%

] Bio Products Laboratory, Limited (BPL), a leading manufacturer of plasma-derived protein therapies, today announced the submission of a Biologics License Supplement (BLS) to the U.S. Food and Drug Administration (FDA) for the use of Gammaplex ...
 TMC Net2 weeks ago Bio Products Laboratory Announces FDA Submission Of Biologics License Supplement For Gammaplex 10%  BioSpace2 weeks ago
[x]  

Mirna Therapeutics Provides Operational Update and Reports Financial Results for Fourth Quarter and Full Year Ended December 31, 2015

Mirna Therapeutics, Inc. (Nasdaq:MIRN), a clinical stage biopharmaceutical company developing a broad pipeline of microRNA-based oncology therapeutics, today reported financial results for the fourth quarter and full year ended December 31, 2015, ...
 Minyanville1 month ago
[x]  
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less